+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Liver Models Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4987003
  • Report
  • February 2020
  • Region: Global
  • 120 pages
  • Mordor Intelligence
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BioIVT
  • CN Bio
  • Cyfuse Biomedical K.K.
  • Emulate, Inc.
  • HuREL Corporation
  • InSphero
  • MORE
The global human liver models market is expected to witness CAGR of 13.5% over the forecast period. The growth is primarily attributed to increasing research and development in healthcare, increasing prevalence of liver diseases and advancements in organ printing technologies. In addition, the increasing focus on developing alternatives for the animal-based models and accuracy in outcomes is projected to boost the market growth. Moreover, increasing prevalence of the non-fatty acid liver disease, alcohol consumption that is leading to liver diseases is anticipated to fuel the market growth over the forecast period. However, the high cost of liver models and issues with the incorporation of liver models into existing workflow are expected to hamper the market growth over the forecast period.

Key Market Trends

Liver-on-a-Chip liver models are expected to Grow at Significant Rate

Liver-on-a-Chip is the bioengineered systems that are able to simulate the key features of the fundamental function of the liver. Liver-on -a-chip are simpler and less expensive compared to other models. Furthermore, owing to the growing demand for low-cost alternatives for animal models for drug discovery and development, the segment is projected to grow at significant rates. The increase in initiatives for liver organoids and technological advancements in human organ modelling is anticipated to fuel the overall market growth.

Moreover, increasing liver infections and use of liver models in the development of many drugs is expected to boost the market growth over the forecast period. According to Center for Disease Control and Prevention (CDC), each year in the United States, about 21,000 men and 8,000 women get liver cancer, and about 16,000 men and 8,000 women die from the disease. Also, the increase in consumption of the alcohol around the world is leading to the liver diseases increasing the demand for liver models.

North America is Expected to have Significant Market Share

North America and Europe are expected to have the majority of the market share owing to increasing R&D expenditure, innovation in the organ models and adoption of innovative potential therapies in the region. Moreover, increasing prevalence of liver diseases coupled with the presence of key market players in the region is anticipated to boost the market growth over the forecast period. Asia Pacific region is expected to expand its share due to increasing R&D investments in developing countries of the region. Moreover, developing healthcare infrastructure and companies focus on the development of new therapeutics expected to bolster regional growth.

Competitive Landscape

Global human liver models market is moderately consolidated and competitive. Market players are focusing on product innovations, new product launches and regional expansions to increase their market share. The key market players operating in the market include Emulate, Inc., InSphero, BioIVT, Organovo Holdings Inc., and Mimetas among others.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client's requirements.
  • 3 months of analyst support.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • BioIVT
  • CN Bio
  • Cyfuse Biomedical K.K.
  • Emulate, Inc.
  • HuREL Corporation
  • InSphero
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases and Geriatric Population
4.2.2 Increasing Demand For Technologically Advanced Stretchers
4.3 Market Restraints
4.3.1 High Cost of Specialized Stretchers
4.3.2 Growing Adoption of Home Healthcare
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product Type
5.1.1 2D Models
5.1.2 3D Models
5.1.3 Liver-on-a-Chip
5.1.4 Others
5.2 Application
5.2.1 Eduction
5.2.2 Drug Discovery
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles
6.1.1 Organovo Holdings Inc.
6.1.2 BioIVT
6.1.3 InSphero
6.1.4 Emulate, Inc.
6.1.5 Mimetas
6.1.6 CN Bio
6.1.7 Cyfuse Biomedical K.K.
6.1.8 HuREL Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Organovo Holdings Inc.
  • BioIVT
  • InSphero
  • Emulate, Inc.
  • Mimetas
  • CN Bio
  • Cyfuse Biomedical K.K.
  • HuREL Corporation
Note: Product cover images may vary from those shown
Adroll
adroll